FDA Grants Accelerated Approval to Ipsen and Genfit's Iqirvo for Liver Disease Treatment
Jun 12, 2024
Iqirvo Invest Information
GENFIT Reaches Historic FDA Approval with Ipsen's Iqirvo® for Primary Biliary Cholangitis
Jun 11, 2024